Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

GSK249320

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background and Purpose— One class of poststroke restorative therapy focuses on promoting axon outgrowth by blocking myelin-based… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
2017
2017
Introduction: One class of potential post-stroke restorative therapy focuses on promoting axon outgrowth by blocking myelin-based… Expand
2016
2016
Myelin-associated glycoprotein (MAG) is an inhibitor of axon growth. MAG levels increase after stroke. GSK249320 is a monoclonal… Expand
  • figure 1
  • figure 4
  • figure 2
  • figure 3
  • figure 5
2015
2015
Background and Purpose— New insights into the brain’s ability to reorganize after injury are beginning to suggest novel… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2014
Review
2014
Introduction Transcranial Magnetic Stimulation (TMS) is a neurophysiological tool capable of assessing the motor nervous system… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2013
2013
Background and Purpose— Restorative therapies have the potential to improve function and reduce disability after stroke with a… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
2013
2013
GSK249320, a monoclonal antibody directed against myelin‐associated glycoprotein (MAG), is being developed for the enhancement of… Expand
2013
2013
OBJECTIVE: Primary: examine safety and tolerability of GSK249320. Secondary: examine immunogenicity, pharmacokinetics, biomarkers… Expand